A Comparative Clinical Study to Evaluate the efficacy of Punarnava amrita Guggulu and Rasnadi Kwath in Cases of Vatarakta with and without Raktmokshan by Jalauka with special reference to Gout
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 60
- 试验地点
- 1
研究概览
简要总结
This clinical trial is a comparative study conducted to evaluate the efficacy of Punarnava Amrita Guggulu and Rasnadi Kwath with and without Raktamokshana by Jaluka in the management of Vatarakta with special reference to Gout. A minimum of 60 patients diagnosed with Vatarakta/Gout will be randomly divided into two groups, where Group A will receive Punarnava Amrita Guggulu (1 g twice daily) along with Rasnadi Kwath (40 ml twice daily), and Group B will receive the same oral medication along with weekly Jaluka Avacharana for one month. The total duration of treatment is 30 days with scheduled follow-ups. Therapeutic efficacy will be assessed based on improvement in subjective parameters such as pain, swelling, tenderness, stiffness, and burning sensation, along with objective evaluation of serum uric acid levels. The study aims to assess the additional role of Raktamokshana as an adjunct to oral Ayurvedic therapy in providing effective, safe, and holistic management of Vatarakta (Gout).
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- None
入排标准
- 年龄范围
- 21.00 Year(s) 至 60.00 Year(s)（—）
入选标准
- •Age: Individuals between 21 and 60 years.
- •Gender: Both males and females will be included.
- •Socioeconomic Status: Participants from all socioeconomic backgrounds are eligible.
- •In case of Jalauka Avcharana BT, CT, INR, within normal limits and patients having HB percent grater than 10 gm percent.
- •Clinical Parameters: Patients diagnosed with Vatarakt who have serum uric acid levels exceeding 7 mg per dl in males and 6 mg per dl in females.
- •Additionally, they must fulfill all three essential diagnostic criteria along with at least one non-essential criterion.
排除标准
- •Individuals younger than 21 years or older than 60 years.
- •In case of Jalauka Avcharana patient having HB percentage less than 10gm percentage, any coagulative disorders, uncontrolled hypertension and Diabetes mellitus.
- •Cases of gouty arthritis complicated by systemic conditions such as uncontrolled diabetes, thyroid dysfunctions, or psoriatic arthritis.
- •Patients with advanced Vatarakta presenting with complications like hiccups, fainting, delirium, erysipelas, muscular abscess, or finger deformities.
- •Gout cases accompanied by chronic joint deformity, significant loss of joint function, or presence of draining tophi.
- •Women who are pregnant or Lactating.,
- •Patients diagnosed with rheumatoid arthritis, osteoarthritis, systemic lupus erythematosus ,tuberculosis, or those suffering from renal or liver disorders.
- •Patients having serum uric acid grater than 10.3 mg per dl in females and grater than 11.6 mg per dl in males.
研究者
Deepraj Singh
State Ayurvedic College and Hospital Lucknow